Tokyo, Japan

Kimihiko Takada

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimihiko Takada. Retrieved from https://idiyas.com/inventor/kimihiko-takada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kimihiko Takada: Innovator in Platinum Complexes

Introduction

Kimihiko Takada is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of platinum complexes. His work focuses on creating compounds with potential applications in medicine, specifically as antitumor agents.

Latest Patents

Takada holds a patent for a platinum (II) complex represented by a specific general formula. This complex is characterized by its unique structure, where A's can be ammonia or specific diamines, and B's represent various alkyl groups. These platinum (II) complexes exhibit high potency for use as antitumor agents, showcasing their potential in cancer treatment.

Career Highlights

Throughout his career, Takada has been associated with Nippon Kayaku Kabushiki Kaisha, a company known for its innovative contributions to the pharmaceutical industry. His work has led to advancements in the development of effective antitumor agents, highlighting his role as a key player in this field.

Collaborations

Takada has collaborated with notable colleagues, including Kenji Iwata and Hisao Ekimoto. These partnerships have fostered a collaborative environment that enhances research and development efforts in their respective projects.

Conclusion

Kimihiko Takada's contributions to the field of platinum complexes demonstrate his commitment to advancing medical science. His innovative work continues to pave the way for new treatments in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…